Company news
Shaanxi Micot Pharmaceutical Technology Co., Ltd. news in 2026
Shaanxi Micot Pharmaceutical Technology Co., Ltd.'s news releases, calls and decks from 2026, newest first.
Announcement in relation to the postponement of the EGM and change of book closure period
November 6, 2026
Voluntary announcement - receipt of the first instalment of project funding under a national major science and technology project and obtaining ethics approval from the lead institution for the phase III clinical trial of MT200605
November 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
November 3, 2026
Proxy form for the extraordinary general meeting to be held on 10 November 2026
October 22, 2026
Notice of extraordinary general meeting
October 22, 2026
Proposed general mandate to repurchase h shares and notice of extraordinary general meeting
October 22, 2026
Proposed adoption of the h share incentive scheme and proposed general mandate to repurchase h shares
October 15, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 6, 2026
Notification letter to non-registered shareholders and reply form
September 30, 2026
2026 Interim report
September 30, 2026
Announcement of allotment results
June 23, 2026
List of directors and their roles and functions
June 22, 2026
Documents on Display
June 14, 2026